Work Groups are chartered by Roundtables to go deep on a key issue over a three-year period, and to make recommendations to Roundtable Fellows for pronouncements or actions that should be taken by the Roundtable, the Forum or by all CEOs. Work Groups are focused on:

• Developing specific mechanisms that advance access to high-quality, affordable health care for all people
• Identifying best practices and developing strategies for wide dissemination so observable results can be realized within 3 years
• Addressing issues that CEOs and boards of payer, provider and life science companies would consider top priorities
• Driving changes where the voice of payer, provider and life science CEOs and their actions matter, where private sector leaders can make progress without regulatory change and which do not require endorsement of specific products or solutions

Chartered Work Groups

Governance and Use of Patient Data in Health IT Products

There has been huge growth and large expectations for the use of patient data in health care, particularly as an adjuvant to clinical decision-making. From image interpretation to diagnosis, payer, provider and life science companies are forming partnerships with technology and data analytics companies to develop new tools and capabilities. However, payer, provider and life science companies face potential public backlash and regulatory scrutiny over data privacy concerns when engaging outside partners to analyze PHI and non-PHI data, and use of patient data in new ways may create health disparities and pose other ethical challenges for payer, provider and life science companies. While the FDA regulates AI tools that are used in diagnosis or treatment, the lack of guidelines for how AI should be developed, how patient data should be used, how AI is applied to various populations (e.g., across races or age groups) and how AI intellectual property is handled puts payer, provider and life science companies at risk. The goal of this Work Group is to articulate standards for responsible innovation to shape the partnerships between payer, provider and life science companies and developers of AI and other analytics and to guide the product development process of data tools for the clinical setting.

Digital Health and App Experience

There are hundreds of thousands of health care apps that influence the health of people who are otherwise patients of health systems and members of health plans. These organizations have no way of knowing which apps people are using or whether they are appropriate for their health status. Likewise, many health systems and health plans have digital strategies that, while thoughtful, result in a piecemeal, arbitrary and fragmented set of apps that patients use. The goal of this Work Group is to identify the best practices for rationalizing patient/member app and digital health experience and to widely disseminate these practices.

Automation and Clinician Burnout

Although clinician burnout has been a longstanding feature of health care, and challenges around COVID-19 have accelerated these trends, the adoption of IT by clinicians has remained the largest ongoing factor in their ability to perform their jobs sustainably and productively. The goal of this Work Group is to reduce the contribution of technology to clinician burnout by identifying technology, workflow and organizational factors that drive burnout and evaluating technology strategies and best practices for reducing the role of these factors.